Clinical Trial Update: Pegylated Interferon Plus Ribavirin in Treating Older Patients With Chronic Hepatitis C [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating pegylated interferon plus ribavirin in older adults with chronic hepatitis C. The study assesses safety and potential e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Copegus (ribavirin)
• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital | Conditions: Chronic Hepatitis C | Phase 4 | Status: COMPLETED